Overview
Anna-karin Lindqvist practices practicing medicine in Lulea, Sweden.
Their clinical expertise encompasses Dystrophic Epidermolysis Bullosa.
They are actively involved in clinical research, co-authoring 29 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Anna-karin Lindqvist
Is Anna-karin Lindqvist a top-rated expert for Dystrophic Epidermolysis Bullosa?
MediFind is an objective health platform that identifies experts based on real-world data. Anna-karin Lindqvist is classified as an Experienced expert for Dystrophic Epidermolysis Bullosa, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Anna-karin Lindqvist participate in research or clinical trials?
Yes. Anna-karin Lindqvist has published 29 articles and abstracts on conditions like Dystrophic Epidermolysis Bullosa. You can view a list of Anna-karin Lindqvist's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Dystrophic Epidermolysis BullosaLindqvist isExperienced. Learn about Dystrophic Epidermolysis Bullosa.